We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+1.55%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$1.06T
AUM Growth
-$16.9B
Cap. Flow
-$16.2B
Cap. Flow %
-1.53%
Top 10 Hldgs %
26.1%
Holding
3,048
New
131
Increased
1,029
Reduced
1,524
Closed
112

Top Buys

Rank Stock Value
1
XYZ
Block Inc
XYZ
+$2.39B
2
CVNA icon
Carvana
CVNA
+$1.82B
3
MSFT icon
Microsoft
MSFT
+$1.5B
4
DIS icon
Walt Disney
DIS
+$1.25B
5
SPOT icon
Spotify
SPOT
+$1.05B

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$2.65B
2
INTU icon
Intuit
INTU
+$2.08B
3
MTCH icon
Match Group
MTCH
+$1.87B
4
CRM icon
Salesforce
CRM
+$1.76B
5
META icon
Meta Platforms (Facebook)
META
+$1.61B

Sector Composition

Rank Sector Weight
1 Technology 25.08%
2 Healthcare 16.24%
3 Consumer Discretionary 15.33%
4 Communication Services 13.82%
5 Financials 12.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QUMU
2801
DELISTED
Qumu Corp.
QUMU
$120K ﹤0.01%
48,550
+19,800
+69% +$52.5K
MNOV icon
2802
MediciNova
MNOV
$64.5M
$119K ﹤0.01%
31,500
PPSI
2803
Pioneer Power Solutions
PPSI
$32.8M
$119K ﹤0.01%
35,800
SCPX
2804
DELISTED
Scorpius Holdings, Inc.
SCPX
$118K ﹤0.01%
5
OTIC
2805
DELISTED
Otonomy, Inc.
OTIC
$118K ﹤0.01%
61,400
+20,000
+48% +$33.9K
ADVM
2806
DELISTED
Adverum Biotechnologies
ADVM
$117K ﹤0.01%
5,410
LFMD icon
2807
LifeMD
LFMD
$161M
$117K ﹤0.01%
18,900
-6,100
-24% -$52K
NGNE icon
2808
Neurogene
NGNE
$733M
$117K ﹤0.01%
807
-970
-55% -$149K
HARP
2809
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$117K ﹤0.01%
1,483
PED icon
2810
PEDEVCO
PED
$155M
$116K ﹤0.01%
3,905
TUSK icon
2811
Mammoth Energy Services
TUSK
$158M
$116K ﹤0.01%
39,800
KPRX icon
2812
Kiora Pharmaceuticals
KPRX
$11.5M
$115K ﹤0.01%
+143
New +$122K
BCEL
2813
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$113K ﹤0.01%
18,134
+6,900
+61% +$46K
ENVB icon
2814
Enveric Biosciences
ENVB
$6.16M
$110K ﹤0.01%
+6
New +$116K
WYY icon
2815
WidePoint Corp
WYY
$112M
$109K ﹤0.01%
20,700
ATYR
2816
aTyr Pharma
ATYR
$55.6M
$109K ﹤0.01%
+12,024
New +$71.9K
BRMK
2817
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
$109K ﹤0.01%
11,027
-160
-1% -$1.66K
FARM
2818
DELISTED
Farmer Brothers
FARM
$108K ﹤0.01%
12,800
-4,200
-25% -$38.5K
APRN
2819
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
$108K ﹤0.01%
1,225
AIOT
2820
PowerFleet Inc
AIOT
$419M
$107K ﹤0.01%
15,900
ATXS
2821
DELISTED
Astria Therapeutics
ATXS
$106K ﹤0.01%
11,966
-1
-0% -$10
IVAC
2822
DELISTED
Intevac Inc
IVAC
$106K ﹤0.01%
22,200
SIGA icon
2823
SIGA Technologies
SIGA
$208M
$105K ﹤0.01%
14,164
ASPS icon
2824
Altisource Portfolio Solutions
ASPS
$62.8M
$104K ﹤0.01%
1,313
CASI
2825
DELISTED
CASI Pharmaceuticals
CASI
$104K ﹤0.01%
8,750
-1,770
-17% -$23.9K

Similar funds

T. Rowe Price Associates's Q3 2021 Portfolio in Review

As of Q3 2021, T. Rowe Price Associates held 3,048 positions worth $1.06T, down 1.6% from $1.08T the previous quarter. Its ten largest holdings account for 26% of the portfolio.

T. Rowe Price Associates's Q3 2021 filing shows 131 new, 1,029 increased, 1,524 reduced and 112 closed positions. Its largest new stake was Warby Parker: 17,643,113 shares worth $936M. The largest sale was Visa, an estimated $2.65B.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q3 2021 buy was Warby Parker: 17,643,113 shares worth $936M.
  • T. Rowe Price Associates added most to Block Inc in Q3 2021, an estimated $2.39B increase.
  • T. Rowe Price Associates's biggest Q3 2021 reduction was Visa, cutting an estimated $2.65B.
  • T. Rowe Price Associates fully exited Maxim Integrated Products in Q3 2021, selling an estimated $394M.
  • T. Rowe Price Associates's ten largest holdings make up 26% of its $1.06T portfolio in Q3 2021.
  • T. Rowe Price Associates opened 131 new positions and closed 112 in Q3 2021.
  • T. Rowe Price Associates's portfolio value fell 1.6% quarter-over-quarter to $1.06T.

Based on T. Rowe Price Associates's 13F filing for Q3 2021, filed 15 Nov 2021.